Cargando…
Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study)
BACKGROUND: Although several coronavirus disease 2019 (COVID-19) vaccines initially showed high efficacy, there have been concerns because of waning immunity and the emergence of variants with immune escape capacity. METHODS: A test-negative design case-control study was conducted in 16 healthcare f...
Autores principales: | Arashiro, Takeshi, Arima, Yuzo, Muraoka, Hirokazu, Sato, Akihiro, Oba, Kunihiro, Uehara, Yuki, Arioka, Hiroko, Yanai, Hideki, Kuramochi, Jin, Ihara, Genei, Chubachi, Kumi, Yanagisawa, Naoki, Nagura, Yoshito, Kato, Yasuyuki, Ueda, Akihiro, Numata, Akira, Kato, Hideaki, Ishii, Koji, Ooki, Takao, Oka, Hideaki, Nishida, Yusuke, Stucky, Ashley, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384625/ https://www.ncbi.nlm.nih.gov/pubmed/35918782 http://dx.doi.org/10.1093/cid/ciac635 |
Ejemplares similares
-
Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan
por: Arashiro, Takeshi, et al.
Publicado: (2023) -
Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies
por: Arashiro, Takeshi, et al.
Publicado: (2023) -
Behavioral factors associated with SARS‐CoV‐2 infection in Japan
por: Arashiro, Takeshi, et al.
Publicado: (2022) -
Comparative effectiveness of the sars-CoV-2 vaccines during delta dominance
por: Islam, Nazmul, et al.
Publicado: (2023) -
SARS 2 human coronavirus (COVID -19, SARS CoV2)
por: McFee, R.B.
Publicado: (2020)